AGTR1 and left ventricular hypertrophy: Of significant clinical interest, losartan is an FDA-approved AGTR1 antagonist for the treatment of hypertension, left ventricular hypertrophy, and diabetic nephropathy, and it has been clinically used for more than two decades with an excellent safety profile [32].